Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. Dec 15, 2019; 11(12): 1172-1181
Published online Dec 15, 2019. doi: 10.4251/wjgo.v11.i12.1172
Table 1 Clinical and pathological characteristics of patients of the two arms, n (%)
VariableS arm (n = 174)S + R arm (n = 56)P value
Sex0.656
Male159 (91.4)49 (87.5)
Female15 (8.6)7 (12.5)
Age (yr)0.056
<60106 (60.9)42 (75.0)
≥6068 (39.1)14 (25.0)
Pathological differentiation0.586
Poor66 (37.5)1 (1.8)
Moderate97 (55.7)33 (58.9)
Well10 (5.7)22 (39.3)
Tumor location0.031a
Upper15 (8.6)3 (5.4)
Middle98 (56.3)22 (39.3)
Lower61 (35.1)31 (55.4)
Lymph node dissection0.448
2-field resection139 (79.9)49 (87.5)
3-field resection28 (16.1)7 (12.5)
No. of LNs involved0.740
≤2113 (64.9)35 (62.5)
≥361 (35.1)21 (37.5)
No. of LNs dissected0.569
<122 (1.1)1 (1.8)
≥12172 (98.9)55 (98.2)
T stage0.075
T3164 (94.3)48 (85.7)
T410 (5.7)8 (14.3)
Chemotherapy0.978
Yes106 (60.9)34 (60.7)
Table 2 Comparison of failure patterns for the two arms, n (%)
Type of failureS arm (n = 174)S + R arm (n = 56)P value
Failure patterns< 0.001
Distant metastasis14 (8.0)36 (64.3)
Locoregional recurrence141 (81.0)14 (25.0)
Mixed failure19 (11.0)6 (10.7)
Distant metastasis< 0.001
Distant metastasis33 (19.0)42 (75.0)
Others141 (81.0)14 (25.0)
Locoregional failure< 0.001
Locoregional recurrence160 (92.0)20 (78.3)
Others14 (8.0)36 (21.7)
Table 3 Univariate and multivariate analyses for factors affecting survival
Univariate analysis
Multivariate analysis
Median DFS (mo)χ2 valueP valueHR (95%CI)P value
Sex0.841 (0.532-1.328)0.457
Male9.50.3090.579
Female8
Age (yr)0.712 (0.530-0.957)0.024
< 6091.0230.312
≥ 609.5
Pathological differentiation1.128 (0.094-1.934)0.071
Poor86.3770.095
Moderate10.4
Well9.5
Tumor location1.423 (0.849-2.386)0.363
Upper6.63.2770.194
Middle9.9
Lower8.8
Lymph node dissection0.531 (0.222-1.186)0.107
2-field resection93.4620.177
3-field resection8
No. of LNs involved1.843 (1.369-2.482)<0.001a
≤ 21113.483< 0.001
≥ 38
No. of LN dissected1.460 (0.459-4.644)0.522
< 1270.6560.418
≥ 129.5
Chemotherapy0.732 (0.552-0.971)0.031
Yes81.7690.183
No10
T stage0.697 (0.441-1.124)0.132
T390.0870.767
T48
Radiotherapy---0.667 (0.487-0.915)0.012a